rivaroxaban
bayer
['invictus', 'rivaroxaban', 'cardio']
#invictus trial: vka reduce #cardiovascular events and mortality, without increasing major bleeding, compared to rivaroxaban in patients with rheumatic heart disease and #atrialfibrillation. #esccongress 
European Society of Cardiology official Twitter account. Join us also on @ESC_Journals @ESCAdvocacy @ESCardioNews #cardiology #ESCCongress #ESCGuidelines